跳至主要内容
临床试验/NCT00398606
NCT00398606已完成3 期

A Triple-Blind, Randomized, Active-Controlled, Parallel-Group, Multicenter Study to Evaluate and Compare the Efficacy and Tolerability of Alendronate Sodium With Calcium Supplementation in the Treatment of Osteoporosis in Postmenopausal Women

Organon and Co0 个研究点目标入组 650 人开始时间: 1995年4月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
650
主要终点
BMD of the lumbar spine determined by a DEXA scan at 2 years

研究概览

简要总结

The purpose of this study is to see how well alendronate and calcium as compared to calcium alone increase bone density in postmenopausal women with osteoporosis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Patient is postmenopausal (or surgically menopausal) for at least 5 years.
  • •Patient must be diagnosed with osteoporosis
  • •Patient has spinal anatomy suitable for DEXA of the lumbar spine

排除标准

  • •Patient is receiving or has received treatment prior to randomization which might influence bone turnover
  • •Patient has a history of or evidence for metabolic bone disease (other than postmenopausal bone loss)
  • •Patient is receiving or is expected to receive during the course of the study any medication (other than study medication) which might alter bone or calcium metabolism

结局指标

主要结局

BMD of the lumbar spine determined by a DEXA scan at 2 years

次要结局

  • BMD of the hip trochanter and femoral neck determined by a DEXA scan and biomarkers of bone turnover (BAP, NTX) at 2 years

研究者

申办方类型
Industry
责任方
Sponsor

相似试验